Cancer Resources
Featured Centers
- Eating Out? Cut Calories, Heartburn
- 5 Good Ways to Save Money on Medicine
- 8 Ways to Treat Your Allergies
Breast Cancer Clinical Trials »
A clinical trial is a research program conducted with patients to evaluate a new medical treatment, drug or device. The purpose of a breast cancer clinical trial is to find new and improved methods of treating the disease. Clinical trials make it possible to apply the latest scientific and technological advances to patient care.
During a breast cancer clinical trial, researchers, usually physicians, use the best available treatment as a standard to evaluate new treatments. These treatments may be a new drug, surgery or an alternative medicine.
First, researchers study new treatment options in the laboratory in test tubes and animals. If those results are promising, new treatments are further evaluated in a small group of people, and, finally, in a larger clinical trial.
When a new medical treatment is studied for the first time in humans, no one knows exactly how it will work. With any new treatment, there are possible risks as well as be...
|
|
MEDICATION GUIDE
SOLTAMOX™ (tamoxifen citrate)
Oral Solution (SOL-ta-mox)
Generic name: tamoxifen citrate
Written for women who use SOLTAMOX™ (tamoxifen citrate) to lower their high chance of getting breast cancer or who have ductal carcinoma in situ (DCIS)
This Medication Guide discusses only the use of SOLTAMOX™ (tamoxifen citrate) to lower the chance of getting breast cancer in high-risk women and in women treated for DCIS.
People taking SOLTAMOX™ (tamoxifen citrate) to treat breast cancer have different benefits and different decisions to make than high-risk women or women with ductal carcinoma in situ (DCIS) taking SOLTAMOX™ (tamoxifen citrate) to reduce the chance of getting breast cancer. If you already have breast cancer, talk with your doctor about how the benefits of treating breast cancer with SOLTAMOX™ (tamoxifen citrate) compare to the risks that are described in this document.
Why should I read this Medication Guide?
This guide has information to help you decide whether to use SOLTAMOX™ (tamoxifen citrate) to lower your chance of getting breast cancer.
You and your doctor should talk about whether the possible benefit of SOLTAMOX™ (tamoxifen citrate) in lowering your high chance of getting breast cancer is greater than its possible risks. Your doctor has a special computer program or hand-held calculator to tell if you are in the high-risk group. If you have DCIS and have been treated with surgery and radiation therapy, your doctor may prescribe SOLTAMOX™ (tamoxifen citrate) to decrease your chance of getting invasive (spreading) breast cancer.
Read this guide carefully before you start SOLTAMOX™ (tamoxifen citrate) . It is important to read the information you get each time you get more medicine. There may be something new. This guide does not tell you everything about SOLTAMOX™ (tamoxifen citrate) and does not take the place of talking with your doctor. Only you and your doctor can determine if SOLTAMOX™ (tamoxifen citrate) is right for you.
What is the most important information I should know about using SOLTAMOX™ (tamoxifen citrate) to reduce the chance of getting breast cancer?
SOLTAMOX™ (tamoxifen citrate) is a prescription medicine that is like estrogen (female hormone) in some ways and different in other ways. In the breast, tamoxifen can block estrogen's effects. Because it does this, tamoxifen may block the growth of breast cancers that need estrogen to grow (cancers that are estrogen- or progesterone-receptor positive).
Tamoxifen citrate can lower the chance of getting breast cancer in women with a higher than normal chance of getting breast cancer in the next five years (high-risk women) and women with DCIS. Because high-risk women don't have cancer yet, it is important to think carefully about whether the possible benefit of tamoxifen in lowering the chance of getting breast cancer is greater than its possible risks.
This Medication Guide reviews the risks and benefits of using SOLTAMOX (tamoxifen citrate) ™ to reduce the chance of getting breast cancer in high-risk women and women with DCIS. This guide does not discuss the special benefits and decisions for people who already have breast cancer.
Why do women and men use SOLTAMOX ™?
SOLTAMOX™ (tamoxifen citrate) has more than one use. SOLTAMOX™ (tamoxifen citrate) is used:
This guide talks only about using SOLTAMOX™ (tamoxifen citrate) to lower the chance of getting breast cancer (#1 and #2 above).
What are the benefits of SOLTAMOX™ (tamoxifen citrate) to lower the chance of getting breast cancer in high-risk women and in women treated for DCIS?
A large US study looked at high-risk women and compared the ones who took tamoxifen for 5 years with others who took a pill without tamoxifen (placebo). High-risk women were defined as women who have a 1.7% or greater chance of getting breast cancer in the next 5 years, based on a special computer program. In this study:
The study showed that on average, high-risk women who took tamoxifen lowered their chances of getting breast cancer by 44%, from 7 in 1,000 to 4 in 1,000.
Another US study looked at women with DCIS and compared those who took tamoxifen for 5 years with others who took a placebo. In this study:
The study showed that on average, women with DCIS who took tamoxifen lowered their chances of getting invasive (spreading) breast cancer by 43%, from 17 in 1,000 to 10 in 1,000.
These studies do not mean that taking SOLTAMOX™ (tamoxifen citrate) will lower your personal chance of getting breast cancer. We do not know what the benefits will be for any one woman who takes SOLTAMOX™ (tamoxifen citrate) to reduce her chance of getting breast cancer.
What are the risks of SOLTAMOX™ (tamoxifen citrate) ?
In the studies described under "What are the benefits of SOLTAMOX™ (tamoxifen citrate) ?, the high-risk women who took tamoxifen got certain side effects at a higher rate than those who took a placebo. Some of these side effects can cause death.
In one study, in women who still had their uterus
These results show that, on average, in high-risk women who still had their uterus, tamoxifen doubled the chance of getting endometrial cancer from 1 in 1,000 to 2 in 1,000, and it increased the chance of getting uterine sarcoma. This does not mean that taking tamoxifen will double your personal chance of getting endometrial cancer or increase your chance of getting uterine sarcoma. We do not know what this risk will be for any one woman. The risk is different for women who no longer have their uterus.
For all women in this study, taking tamoxifen increased the risk of having a blood clot in their lungs or veins, or of having a stroke. In some cases, women died from these effects.
Tamoxifen increased the risk of getting cataracts (clouding of the lens of the eye) or needing cataract surgery. (See "What are the possible side effects of SOLTAMOX™ (tamoxifen citrate) for more details about side effects.)
What don't we know about taking SOLTAMOX™ (tamoxifen citrate) to reduce the chance of getting breast cancer?
We don't know
Studies are being done to learn more about the long-term benefits and risks of using tamoxifen to reduce the chance of getting breast cancer.
What are the possible side effects of SOLTAMOX™ (tamoxifen citrate) ?
The most common side effect of tamoxifen is hot flashes. This is not a sign of a serious problem.
The next most common side effect is vaginal discharge. If the discharge is bloody, it could be a sign of a serious problem. [See "Changes in the lining (endometrium) or body of your uterus" below.]
Less common but serious side effects of tamoxifen are listed below. These can occur at any time. Call your doctor right away if you have any signs of side effects listed below:
Another less serious side effect that has been reported occasionally with SOLTAMOX™ (tamoxifen citrate) is mild, temporary throat irritation. These are not all the possible side effects of tamoxifen. For a complete list, ask your doctor or pharmacist.
Who should not take SOLTAMOX™ (tamoxifen citrate) ?
Do not take tamoxifen for any reason if you
If you get pregnant while taking SOLTAMOX™ (tamoxifen citrate) , stop taking it right away and contact your doctor. SOLTAMOX™ (tamoxifen citrate) may harm your unborn baby.
Do not take SOLTAMOX™ (tamoxifen citrate) to lower your chance of getting breast cancer if
How should I take SOLTAMOX™ (tamoxifen citrate) ?
What should I avoid while taking SOLTAMOX™ (tamoxifen citrate) ?
What should I do while taking SOLTAMOX™ (tamoxifen citrate) ?
General information about the safe and effective use of SOLTAMOX™ (tamoxifen citrate)
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Your doctor has prescribed SOLTAMOX™ (tamoxifen citrate) only for you. Do not give it to other people, even if they have a similar condition, because it may harm them. Do not use it for a condition for which it was not prescribed.
This Medication Guide is a summary of information about SOLTAMOX™ (tamoxifen citrate) for women who use SOLTAMOX™ (tamoxifen citrate) to lower their high chance of getting breast cancer or who have DCIS. If you want more information about SOLTAMOX™ (tamoxifen citrate) , ask your doctor or pharmacist. They can give you information about SOLTAMOX™ (tamoxifen citrate) that is written for health professionals. For more information about SOLTAMOX™ (tamoxifen citrate) or breast cancer, please visit www.savientpharma.com or call 1-866-692-6374.
Ingredients: tamoxifen, ethanol, glycerol, propylene glycol, sorbitol solution, licorice flavor, aniseed flavor, purified water.
Last reviewed on RxList: 11/24/2008
This monograph has been modified to include the generic and brand name in many instances.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find support and advances in treatment.